‌

US Patent 11001583 Dihydropyrrolopyridine inhibitors of ROR-gamma

Patent 11001583 was granted and assigned to Vitae Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Vitae Pharmaceuticals

Current Assignee

Vitae Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110015830

Patent Inventor Names

Yi Fan0

Stephen D. Lotesta0

Suresh B. Singh0

Wei Zhao0

Andrew Marcus0

Chengguo Dong0

Colin M. Tice0

David A. Claremon0

...

Date of Patent

May 11, 2021

Patent Application Number

163947640

Date Filed

April 25, 2019

Patent Citations

‌

US Patent 10087184 Dihydropyrrolopyridine inhibitors of RORγ

‌

US Patent 10399976 Dihydropyrrolopyridine inhibitors of ROR-gamma

‌

US Patent 10047085 Dihydropyrrolopyridine inhibitors of ROR-gamma

‌

US Patent 10301261 Substituted indoles as modulators of ROR-gamma

Patent Citations Received

‌

US Patent 11535614 Dihydropyrrolopyridine inhibitors of ROR-gamma

Patent Primary Examiner

‌

David K O'Dell

Patent abstract

Provided are novel compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11001583 Dihydropyrrolopyridine inhibitors of ROR-gamma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API